|
| |
GlioblastomaDownload PDF containing detailed information.
Recent Publications on Glioblastoma: |  |
Concurrent sequence variation of TP53 and TP73 genes in anaplastic astrocytoma.
Disruption or loss of tumor suppressor gene TP53 is implicated in the... | 31st October, 2009
| Departamento de Genetica, Laboratorio de Oncogenetica, Faculdade de
| Genet Mol Res. 2009 Oct 20;8(4):1257-63.
DOI Direct Link |
Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion.
B7 homolog 1 (B7-H1) is a recently discovered immunoresistance protein... | 31st October, 2009
| Department of Neurological Surgery, University of California at San
| Neuroreport. 2009 Oct 28.
DOI Direct Link |
Automated Brain Tumor Biopsy Prediction Using Single-labeling cDNA Microarrays-based Gene Expression Profiling.
AIMS: Gene signatures obtained from microarray experiments may be of use... | 29th October, 2009
| *Grup d'aplicacions Biomediques de la RMN (GABRMN), Departament de
| Diagn Mol Pathol. 2009 Oct 26.
DOI Direct Link |
Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients.
PURPOSE: Despite multimodal aggressive treatment glioblastoma patients... | 29th October, 2009
| Authors' Affiliations: Departments of Neuropathology and Neurosurgery,
| Clin Cancer Res. 2009 Oct 27.
DOI Direct Link |
Genomic and Expression Profiling of Glioblastoma Stem Cell-Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival.
PURPOSE: Glioblastoma spheroid cultures are enriched in tumor stem-like... | 29th October, 2009
| Authors' Affiliations: Division of Molecular Genetics, Clinical
| Clin Cancer Res. 2009 Oct 27.
DOI Direct Link |
→View more research publications. |
Press Releases About Glioblastoma:
|
 |
| Ascenta Therapeutics Announces Presentation of Results From a Dose-Ranging Study of AT-101 With Standard Therapy in Patients With Glioblastoma Multiforme |
26th October, 2009 |
Ascenta Therapeutics, Inc. |
MALVERN, Pa., Oct. 26 /PRNewswire/ -- Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral,
|
| NexGenix Pharmaceuticals Awarded Phase I Grant from the National Institute of Neurological Disorders and Stroke (NINDS) Small Business Innovation Research Program (SBIR) for the Development of Novel Small Molecule Hsp90 Therapeutics to Treat Glioma |
22nd October, 2009 |
NexGenix Pharmaceuticals Holdings, Inc. |
NEW YORK, Oct. 22 /PRNewswire/ -- NexGenix Pharmaceuticals Holdings, Inc. a privately-held biotechnology company with a portfolio of novel targeted therapies for oncology and neurodegenerative
|
| Video: Groundbreaking Project Launched to Improve Brain Cancer Treatments and Outcomes |
22nd October, 2009 |
Swedish Neuroscience Institute |
SEATTLE, Oct. 22 /PRNewswire-USNewswire/ -- A major collaborative research project focused on mapping the gene activity in brain tumors was launched today. The goal of the research, known as the Ivy
|
| Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain |
21st October, 2009 |
Northwest Biotherapeutics, Inc. |
BETHESDA, M.D., Oct. 21 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) today announced further long-term follow-up
|
| National Cancer Coalition Announces Angel Grant Recipients |
30th July, 2009 |
National Cancer Coalition |
RALEIGH, N.C., July 30 /PRNewswire-USNewswire/ -- The National Cancer Coalition (NCC) is pleased to announce its recent Angel Grant recipients, which include: Dr. Steven Brem of the H. Lee Moffitt
|
Companies working in the area of Glioblastoma from Bioportfolio's Biocorporate database : | |
| Company Name | |
Allos Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative drugs for improving cancer treatments. Since 1994, we have been committed to improving the health...
www.allos.com/ View full profile
| |
BSD Medical Corporation (AMEX: BSM) develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency (RF) and...
www.bsdmc.com/ View full profile
| |
EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them. EntreMed is...
www.entremed.com/ View full profile
| | →View more Glioblastoma related companies. |
BioPortfolio Ltd. offers e-mail and postal lists for Glioblastoma scientists - we have details of around 1290 individuals working on Glioblastoma .
This page has been viewed 1088 times
Recent Search Terms used to find this page: glioblastoma 2009 | Enhanced MDR1 Expression and Chemoresistance of Cancer Stem Cells Derived from Glioblastoma | glioblastoma center of excellence | gliobastoma AND companies | glioblastoma 2009 | glioblastoma class action | 2009 glioblastoma oleander | selenium glioblastoma 2009 | glioblastoma october 2009 | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Glioblastoma across BioPortfolio, or for Glioblastoma Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
